Nordic Bioproducts Group

Nordic Bioproducts Group

Private
EspooFrontier & Industrial Techhttps://nordicbioproducts.fi/

Last Round

Strategic

Jan 27, 2026

Momentum Score

25 /100

Company Overview

Nordic Bioproducts Group is a biomaterials company that develops and commercializes smart biotechnologies to convert cellulose into high-value bioproducts for industries such as pharmaceuticals, food, and cosmetics.

Sector

Frontier & Industrial Tech

Verticals

Sustainable Materials, Advanced Materials, Biotechnology, Clean Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

microcrystalline celluloseMCCAaltoCellbiomaterialssustainable materialspharmaceutical excipientsplant-based textile fiberbiobased materialssustainable textilesclean manufacturingfood ingredientscosmetic ingredientsbiomass conversioncellulose chemistrytechnology licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nordic Bioproducts Group Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Nordic Bioproducts Group Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
StrategicJan 27, 2026
GrantSep 1, 2024
GrantJul 16, 2024
GrantJan 1, 2024
VC RoundMay 16, 2023
VC Round
Mar 30, 2023

Key People

Founding team and executive leadership

Kari Vanhatalo

Chief Technology Officer

Executive Team

Kalle Riihinen

Chief Operating Officer

Executive Team

Nordic Bioproducts Group Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors increased 130% MoM.

Nordic Bioproducts Group Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nordic Bioproducts Group Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nordic Bioproducts Group's valuation, stock price, and market status.

Firmographic Details

HeadquartersEspoo
Employee Range23
Year Founded2019
Last FundingJan 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.